Rheumatic mitral valve repair or replacement in the valve-in-valve era.

ABSTRACT:

Objective

For degenerative mitral disease, repair is superior to replacement; however, the best operative strategy for rheumatic mitral disease remains unclear. We evaluated the association between decision-making in choosing repair versus replacement and outcomes across 2 decades of rheumatic mitral surgery.

Methods

Patients undergoing isolated, first-time rheumatic mitral surgery were identified. Era 1 (1997-2008) and Era 2 (2009-2018) were distinguished by intraoperative assessment of anterior leaflet mobility/calcification (Era 2) in deciding between mitral repair versus replacement. Primary outcome was a composite of death, reoperation, and severe valve dysfunction.

Results

Among 180 patients, age was 59 ± 14 years, and ejection fraction was 58% ± 10%. A higher p

SUBMITTER: Brescia AA 

PROVIDER: S-EPMC7655552 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature